Individualizing therapy for pancreatic cancer.
Colvin
Emily K
EK
Chang
David K
DK
Merrett
Neil D
ND
Kench
James G
JG
Biankin
Andrew V
AV
D014408:Biomarkers, Tumor / Q000032:analysis*; D018395:CA-19-9 Antigen / Q000032:analysis; D006801:Humans; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D020932:Nerve Growth Factor / Q000032:analysis; D010190:Pancreatic Neoplasms / Q000737:chemistry / Q000473:pathology / Q000628:therapy*; D018579:Patient Selection; D011237:Predictive Value of Tests; D020917:Receptor, trkA / Q000032:analysis; D012008:Recurrence; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; D020932:Nerve Growth Factor; D020917:Receptor, trkA